Fractyl Health, Inc. (GUTS) vs PDS Biotechnology Corporation (PDSB)

A side-by-side comparison of Fractyl Health, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Fractyl Health, Inc. logo
GUTS
Fractyl Health, Inc.
$60M
$4.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PDS Biotechnology Corporation logo
PDSB
PDS Biotechnology Corporation
$58M
$1.05HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GUTS vs PDSB

growth of $100 · dividends reinvested · last 3y
GUTS -97.0% (-69.1%/yr)PDSB -77.6% (-39.2%/yr)PDSB compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$3$22
GUTS PDSB

GUTS vs PDSB: by the numbers

  • •GUTS is the larger company ($60M vs $58M market cap).

Metrics side by side

Profitability

MetricGUTSPDSB
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROIC-129.67%-3699.99%

Growth (annualized)

MetricGUTSPDSB
Total return CAGR (5Y)N/A-39.13%

Go deeper

Full GUTS analysisFull PDSB analysisInteractive comparison tool

Dig into the metrics

Fractyl Health ROEPDS Biotechnology ROEFractyl Health operating marginPDS Biotechnology operating marginFractyl Health revenue growthPDS Biotechnology revenue growthFractyl Health free cash flowPDS Biotechnology free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.